Debanjan Ray News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Dupixent Redux? Synthekine, Sanofi Partner on Cytokine Therapies

Dupixent Redux? Synthekine, Sanofi Partner on Cytokine Therapies
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

Debanjan rayK christopher garciaJohn bertinHoward hughes medical instituteMerck coStanford university school of medicineRegeneron pharmaceuticalsGetty imagesMenlo parkStanford university school

Normunity appoints industry leader Debanjan Ray to Board of Directors

BOSTON & WEST HAVEN, Conn. (BUSINESS WIRE) Normunity, Inc., a biotechnology company creating novel precision anti-cancer immunotherapies, today announced the appointment of Debanjan Ray, MBA, to its board of directors. Mr. Ray currently serves as President and Chief Executive Officer of Synthekine, and he has serv.

United statesMassachusetts institute of technologyRachel humphreyDebanjan rayNormunity incUniversity of pennsylvaniaMckinsey companyPortola pharmaceuticalsBristol myers squibbWharton schoolBusiness development at itero biopharmaceuticalsLieping chen at yale school of medicineChief executive officerChief financial officerCytomx therapeuticsBusiness development

Synthekine, Merck partner to develop new cytokine-based therapies

Synthekine, Merck partner to develop new cytokine-based therapies
pharmaceutical-business-review.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmaceutical-business-review.com Daily Mail and Mail on Sunday newspapers.

Debanjan rayMerck research laboratoriesResearch laboratories

Stanford spinout Synthekine raises $107 5M on promise of new way to attack cancer, autoimmune diseases

Stanford spinout Synthekine raises $107 5M on promise of new way to attack cancer, autoimmune diseases
bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.

United statesMenlo parkStanford universityRock springsSan franciscoChris garciaRon leutyPatrick lupardusNaiyer rizviDebanjan rayRobin knifsendLaurene powell jobsRob kasteleinActerlion pharmaceuticalsPortola pharmaceuticals incMerck co

Synthekine Strengthens Leadership with Board of Directors Expansion and Scientific Advisory Board Formation

Published: Feb 04, 2021 MENLO PARK, Calif. (BUSINESS WIRE) Synthekine Inc., an engineered cytokine therapeutics company, today announced that it has appointed Pablo Cagnoni, M.D., to its board of directors. Dr. Cagnoni brings to Synthekine extensive leadership experience in the biotech industry and a successful track record of oncology drug development. The company also announced the formation of its scientific advisory board to help guide the company’s extensive cytokine engineering efforts. “Synthekine has made significant advances in 2020, with our first programs on track for IND filings in 2021, and I am delighted to have Pablo join our board of directors and bring his considerable insights in developing breakthrough oncology products to support our continued progress,” said Debanjan Ray, CEO of Synthekine. “At the same time, our distinguished scientific advisory board will provide guidance as we apply our multiple cytokine engineering efforts to importan

University of pennsylvaniaUnited statesChristophera hunterE john wherryDebanjan rayPablo cagnoniK christopher garciaNils lonbergAllos therapeuticsUniversity of pennsylvania institute for immunologyUniversity of pennsylvania school veterinary medicineUniversity of alabama at birminghamNational academy of medicineNational academy of sciencesSynthekine incOnyx pharmaceuticals